EstechPharma Co. Ltd (041910) — Cash Flow Reinvestment Rate
EstechPharma Co. Ltd (041910) has a Cash Flow Reinvestment Rate of 2.95x as of December 2025, reinvesting ₩7.02 Billion (capex ₩11.20 Million plus investments ₩7.01 Billion) from operating cash flow of ₩2.38 Billion. Check EstechPharma Co. Ltd (041910) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
EstechPharma Co. Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for EstechPharma Co. Ltd across 12 annual periods. Explore how much of EstechPharma Co. Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for EstechPharma Co. Ltd (2013–2025)
Year-by-year capital reinvestment analysis for EstechPharma Co. Ltd. For live market cap and broader valuation context, see EstechPharma Co. Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | ₩4.53 Billion | ₩8.83 Billion | ₩554.56 Million | ▼ -68.5% |
| 2024 | 1.63x | ₩12.89 Billion | ₩7.93 Billion | ₩5.45 Billion | ▼ -35.7% |
| 2023 | 2.53x | ₩12.10 Billion | ₩4.79 Billion | ₩1.02 Billion | ▼ -83.3% |
| 2021 | 15.11x | ₩9.12 Billion | ₩603.42 Million | ₩2.00 Billion | ▲ +2194.6% |
| 2020 | 0.66x | ₩3.10 Billion | ₩4.71 Billion | ₩2.20 Billion | ▼ -81.5% |
| 2019 | 3.56x | ₩15.27 Billion | ₩4.29 Billion | ₩1.13 Billion | ▲ +2432.7% |
| 2018 | 0.14x | ₩1.02 Billion | ₩7.25 Billion | ₩466.07 Million | ▼ -67.7% |
| 2017 | 0.44x | ₩3.04 Billion | ₩6.99 Billion | ₩691.73 Million | ▲ +37.7% |
| 2016 | 0.32x | ₩2.59 Billion | ₩8.19 Billion | ₩2.09 Billion | ▼ -83.0% |
| 2015 | 1.86x | ₩19.42 Billion | ₩10.46 Billion | ₩4.80 Billion | ▲ +21.9% |
| 2014 | 1.52x | ₩7.60 Billion | ₩4.99 Billion | ₩1.24 Billion | ▲ +959.0% |
| 2013 | 0.14x | ₩1.47 Billion | ₩10.19 Billion | ₩1.47 Billion | — |